{"id":"https://openalex.org/W3203203743","doi":"https://doi.org/10.1016/j.biopha.2021.112226","title":"A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer","display_name":"A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer","publication_year":2021,"publication_date":"2021-09-24","ids":{"openalex":"https://openalex.org/W3203203743","doi":"https://doi.org/10.1016/j.biopha.2021.112226","mag":"3203203743","pmid":"https://pubmed.ncbi.nlm.nih.gov/34649352","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9886492"},"language":"en","primary_location":{"id":"doi:10.1016/j.biopha.2021.112226","doi":"https://doi.org/10.1016/j.biopha.2021.112226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2021.112226","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0753332221010106/pdf","source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S0753332221010106/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014071552","display_name":"Eric Zhuang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Zhuang","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029026130","display_name":"Edward Uchio","orcid":"https://orcid.org/0009-0003-2256-6953","observed_orcids":["https://orcid.org/0009-0003-2256-6953"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Uchio","raw_affiliation_strings":["Department of Urology, University of California Irvine,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of California Irvine,\u00a0USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103517019","display_name":"Michael B. Lilly","orcid":"https://orcid.org/0000-0001-9000-3608","observed_orcids":["https://orcid.org/0000-0001-9000-3608"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lilly","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036496290","display_name":"Xiaolin Zi","orcid":"https://orcid.org/0000-0002-5312-7158","observed_orcids":["https://orcid.org/0000-0002-5312-7158"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaolin Zi","raw_affiliation_strings":["Department of Urology, University of California Irvine,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of California Irvine,\u00a0USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061918246","display_name":"John P. Fruehauf","orcid":"https://orcid.org/0000-0002-9447-9440","observed_orcids":["https://orcid.org/0000-0002-9447-9440"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John P. Fruehauf","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA. Electronic address: jfruehau@uci.edu","Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA. Electronic address: jfruehau@uci.edu","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]},{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, USA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061918246"],"corresponding_institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"],"apc_list":{"value":2660,"currency":"USD","value_usd":2660},"apc_paid":{"value":2660,"currency":"USD","value_usd":2660},"fwci":2.9178,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.92193834,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"143","issue":null,"first_page":"112226","last_page":"112226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lycopene","display_name":"lycopene","score":1.0},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.8320000171661377},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.8370000123977661},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6850000023841858},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9229204654693604},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8634580969810486},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6029929518699646},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.59271240234375},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5140982270240784},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5081183910369873},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4772219955921173},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.420229434967041},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4117646813392639},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.405388742685318},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.38408520817756653},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.36547768115997314},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3626391887664795},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3449859023094177},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.1325581967830658}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077276","descriptor_name":"Lycopene","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077276","descriptor_name":"Lycopene","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002140","descriptor_name":"California","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007610","descriptor_name":"Kallikreins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.biopha.2021.112226","doi":"https://doi.org/10.1016/j.biopha.2021.112226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2021.112226","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0753332221010106/pdf","source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:34649352","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34649352","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:9886492","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9886492","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Biomed Pharmacother","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3af830758503416fb585ba3dac4fcb3c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/3af830758503416fb585ba3dac4fcb3c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biomedicine & Pharmacotherapy, Vol 143, Iss , Pp 112226- (2021)","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt76t8d0qf","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/76t8d0qf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.biopha.2021.112226","doi":"https://doi.org/10.1016/j.biopha.2021.112226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2021.112226","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0753332221010106/pdf","source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G9000877839","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA062203","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332688","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337616","display_name":"Chao Family Comprehensive Cancer Center","ror":"https://ror.org/04gyf1771"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203203743.pdf","grobid_xml":"https://content.openalex.org/works/W3203203743.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1496974689","https://openalex.org/W1972912578","https://openalex.org/W1974135773","https://openalex.org/W1987412338","https://openalex.org/W1990134102","https://openalex.org/W2007681149","https://openalex.org/W2036779844","https://openalex.org/W2042641573","https://openalex.org/W2106187131","https://openalex.org/W2118495034","https://openalex.org/W2120292596","https://openalex.org/W2126677162","https://openalex.org/W2142054229","https://openalex.org/W2151063703","https://openalex.org/W2165088640","https://openalex.org/W2296253991","https://openalex.org/W2523396458","https://openalex.org/W2740979023","https://openalex.org/W3007247774","https://openalex.org/W3119005666","https://openalex.org/W3119125273","https://openalex.org/W3159588299"],"related_works":["https://openalex.org/W3134090473","https://openalex.org/W4393097996","https://openalex.org/W2502702344","https://openalex.org/W2745319718","https://openalex.org/W2042641573","https://openalex.org/W3087938960","https://openalex.org/W2099338693","https://openalex.org/W2064536538","https://openalex.org/W2029464116","https://openalex.org/W2591499908"],"abstract_inverted_index":{"was":[0,14,43,64,93,104,116,176],"given":[1],"every":[2],"21":[3],"days":[4],"with":[5],"daily":[6],"oral":[7],"lycopene":[8,192],"30":[9],"mg.":[10],"The":[11],"primary":[12],"endpoint":[13],"a":[15,82],"\u226550%":[16],"reduction":[17],"in":[18,66],"PSA.":[19],"Secondary":[20],"endpoints":[21],"were":[22,36,126],"median":[23,149,165],"time":[24,89],"to":[25,90,156,179],"PSA":[26,62,91,143,159],"progression,":[27],"duration":[28,100],"of":[29,86,101,146,151,189],"response":[30,63,102,144,160],"and":[31,59,148,162,191],"overall":[32,111],"survival.":[33],"Thirteen":[34],"patients":[35,48,54,68,76,129],"initiated":[37],"on":[38],"protocol":[39],"therapy.":[40],"Median":[41,88,99,110],"age":[42],"77":[44],"(range":[45],"55-90).":[46],"Twelve":[47],"(92%)":[49],"had":[50,56,77],"bone":[51,58],"metastases.":[52,61],"Four":[53],"(30%)":[55],"both":[57],"visceral":[60],"seen":[65],"10":[67],"(76.9%":[69],"[95%":[70,96,107,119],"confidence":[71],"interval":[72],"(CI),":[73],"46.2-94.9%]).":[74],"Two":[75],"stable":[78],"disease":[79,83],"(SD),":[80],"yielding":[81],"control":[84],"rate":[85,145,161],"92%.":[87],"progression":[92],"8":[94],"months":[95,106,118,153,164],"CI,":[97,108],"3.5-8.7].":[98],"(DOR)":[103],"7.3":[105],"4.8-13.2].":[109],"survival":[112,150,166],"at":[113],"5":[114],"years":[115],"35.1":[117,152],"CI":[120],"25.7-57.7].":[121],"No":[122,128],"new":[123],"safety":[124],"signals":[125],"noted.":[127],"experienced":[130,139],"grade":[131],"3":[132],"or":[133],"above":[134],"anemia.":[135],"One":[136],"patient":[137],"(7%)":[138],"febrile":[140],"neutropenia.":[141],"A":[142],"76.9%":[147],"compares":[154],"favorably":[155],"the":[157,169,187],"45%":[158],"17.4":[163],"reported":[167],"for":[168],"TAX":[170],"237":[171],"trialists.":[172],"While":[173],"our":[174,183],"study":[175],"limited":[177],"due":[178],"small":[180],"sample":[181],"size,":[182],"results":[184],"suggest":[185],"that":[186],"combination":[188],"docetaxel":[190],"merits":[193],"further":[194],"study.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-10-11T00:00:00"}